| Authors: |
Umei M; Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, National Heart and Lung Institute, Imperial College London, London, UK m-umei@umin.ac.jp., Diller GP; Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, National Heart and Lung Institute, Imperial College London, London, UK.; Adult Congenital and Valvular Heart Disease Center, Department of Cardiology and Angiology, University Hospital Munster Department of Cardiology III Congenital Heart Defects and Valve Diseases, Münster, Germany., Brida M; Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, National Heart and Lung Institute, Imperial College London, London, UK., Aw TC; Department of Anaesthesia and Critical Care, Royal Brompton Hospital, London, UK., Hoschtitzky A; Department of Congenital Cardiac Surgery, Royal Brompton and Harefield Hospitals, London, UK., Kempny A; Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, National Heart and Lung Institute, Imperial College London, London, UK., Gatzoulis MA; Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, National Heart and Lung Institute, Imperial College London, London, UK. |
